Radical Pelvic Surgery-Associated Sexual Dysfunction

Standard Practice in Sexual Medicine

Volumn , Issue , 2008, Pages 210-224

  Mulhall, John ^a,b   Glina, Sidney ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Instituto H Ellis   (Brazil)

Author keywords

Erectile function; Orgasm; Pelvic surgery; Penile length; Sexual dysfunction

Indexed keywords

EID: 84889362803     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470755235.ch17     Document Type: Chapter

References (90)

1. Fraiman MC, Lepor H, McCullough AR. Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical retropubic prostatectomy. Mol Urol 1999;3:109.
2. Munding MD, Wessells HB, Dalkin BL. Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy. Urology 2001;58:567.
3. Savoie M, Kim SS, Soloway MS. A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J Urol 2003;169: 1462.
4. Ciancio SJ, Kim ED. Penile fibrotic changes after radical retropubic prostatectomy. BJU Int 2000;85:101.
5. Carrier S, Zvara P, Nunes L, et al. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol 1995;153:1722.
6. Klein LT, Miller MI, Buttyan R, et al. Apoptosis in the rat penis after penile denervation. J Urol 1997;158:626.
7. User HM, Hairston JH, Zelner DJ, et al. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003;169: 1175.
8. Leungwattanakij S, Bivalacqua TJ, Usta MF, et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003;24:239.
9. Moreland RB. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998;10:113.
10. Sattar AA, Salpigides G, Vanderhaeghen JJ, et al. Cavernous oxygen tension and smooth muscle fibers: relation and function. J Urol 1995;154:1736.
11. Daley JT, Brown ML, Watkins T, et al. Prostanoid production in rabbit corpus cavernosum: I. regulation by oxygen tension. J Urol 1996;155:1482.
12. Moreland RB, Traish A, McMillin MA, et al. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 1995;153:826.
13. Zhou S, Chen LS, Miyauchi Y, et al. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 2004;95:76.
14. Bergman B, Nilsson S, Petersen I. The effect on erection and orgasm of cystectomy, prostatectomy and vesiculectomy for cancer of the bladder: a clinical and electromyographic study. Br J Urol 1979;51:114.
15. Goriunov VG, Davidov MI. Sexual readaptation after the surgical treatment of benign prostatic hyperplasia. Urol Nefrol 1997;(Mosk):20.
16. Koeman M, van Driel MF, Schultz WC, et al. Orgasm after radical prostatectomy. Br J Urol 1996;77:861.
17. Perez MA, Skinner EC, Meyerowitz BE. Sexuality and intimacy following radical prostatectomy: patient and partner perspectives. Health Psychol 2002;21:288.
18. Snyder DK, Berg P. Determinants of sexual dissatisfaction in sexually distressed couples. Arch Sex Behav 1983;12:237.
19. Barnas JL, Parker M, Guhring P, Mulhall JP. The utility of alpha adrenergic blockade in the management of dysorgasmia, 2004.
20. Steg A, Zerbib M, Conquy S. Sexual disorders after an operation for benign prostatic hypertrophy. Ann Urol (Paris) 1988;22:129.
21. Hetrick DC, Ciol MA, Rothman I, et al. Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case-control study. J Urol 2003;170:828.
22. Lee J, Fleshner N, Hersey K. Climacturia following radical prostatectomy: incidence and risk factors. J Urol 2005, Abstract 1249.
23. Abousassaly R, Gill I, Lakin M. Ejaculatory incontinence after radical prostatectomy: a review of 26 cases. J Sex Med 2005, SMSNA Annual Meeting Supplement.
24. Choi JM, Nelson C, Mulhall JP. Orgasm associated incontinence following radical pelvic surgery: prevalence and predictors. J Urol 2006.
25. Lue TF. Impotence after prostatectomy. Urol Clin North Am 1990;17:613.
26. Talcott JA, Rieker P, Propert KJ, et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 1997;89:1117.
27. Aboseif S, Shinohara K, Breza J, et al. Role of penile vascular injury in erectile dysfunction after radical prostatectomy. Br J Urol 1994;73:75.
28. Lue TF. Erectile dysfunction. N Engl J Med 2000; 342:1802.
29. Mulhall JP, Slovick R, Hotaling J, et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002;167:1371.
30. Ohebshalom M, Parker M, Waters WB, Flanigan RC, Mulhall JP. Erectile hemodynamic status following tadical prostatectomy correlates with erectile function outcomes. Presented at the Annual Meeting of the Sexual Medicine Society of North America, New York, 2005.
31. Canada AL, Neese LE, Sui D, et al. Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer 2005; 104:2689.
32. Schover LR, Fouladi RT, Warneke CL, et al. Seeking help for erectile dysfunction after treatment for prostate cancer. Arch Sex Behav 2004;33:443.
33. Carrier S, Zvara P, Nunes L, et al. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol 1995;153:1722.
34. Mullerad M, Donohue JF, Li PS, Scardino PT, Mulhall JP. Functional sequelae of cavernous nerve injury in the rat: Model dependency. J Sex Med 2005;1:39.
35. Bates TS, Wright MP, Gillatt DA. Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire. Eur Urol 1998;33:165.
36. Begg CB RE, Bach PB, Kattan MW, Schrag D, Warren JL, Scardino PT. Variations in morbidity after radical prostatectomy. N Engl J Med 2002;346:1138.
37. Catalona WJ, Basler JW. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993;150:905.
38. Fowler FJ, Barry MJ, Lu-Yao G, et al. Patient-reported complications and follow-up treatment after radical prostatectomy. The national medicare experience: 1988-1990 (updated June 1993). Urology 1993; 42:622.
39. Gralnek D, Wessells H, Cui H, et al. Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy. J Urol 2000;163:1166.
40. Litwin MS, Flanders SC, Pasta DJ, et al. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1999;54:503.
41. Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer. The prostate cancer outcomes study. JAMA 2000;283:354.
42. Talcott JA, Rieker P, Clark JA, et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol 1998;16:275.
43. Walsh PC, Marschke P, Ricker D, et al. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000;55:58.
44. Lue TF, Gleason CA, Brock GB, et al. Intraoperative electrostimulation of the cavernous nerve: technique, results and limitations. J Urol 1995;154:1426.
45. Klotz L, Herschorn S. Early experience with intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy. Urology 1998;52:537.
46. Klotz L, Heaton J, Jewett M, Chin J, Fleshner N, Goldenberg L, Gleave M. A randomized phase 3 study of intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy. J Urol 2000;164:1573.
47. Kim HL, Stoffel DS, Mhoon DA, Brendler CB. A positive Cavermap response poorly predicts recovery of potency after radical prostatectomy. Urology 2000;56:561.
48. Holzbeierlein J, Peterson M, Smith JJ. Variability of results of cavernous nerve stimulation during radical prostatectomy. J Urol 2001;165:108.
49. Chang SS, Peterson M, Smith JA. Intraoperative nerve stimulation predicts postoperative potency. Urology 2001;58:594.
50. Walsh PC, Marschke P, Catalona WJ, Lepor H, Martin S, Myers RP, Steiner MS. Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multiinstitutional evaluation by experienced surgeons. Urology 2001;57:491.
51. Quinlan DM, Nelson RJ, Walsh PC. Cavernous nerve grafts restore erectile function in denervated rats. J Urol 1991;145:380.
52. Kim ED, Hampel O, Mill N, et al. Cavernous nerve grafting restores partial erections after non-nerve sparing radical retropubic prostatectomy. J Urol 1999; 161:188.
53. Kim ED, Kadmon K, Miles BJ, et al. Bilateral nerve grafts during radical retropubic prostatectomy: a one year follow-up. J Urol 2001;165:1950.
54. Kim ED, Scardino PT, Kadmon D, et al. Interposition sural nerve grafting during radical prostatectomy. Urology 2001;57:211.
55. Chang DW, Wood CG, Kroll SS, et al. Cavernous nerve reconstruction to preserve erectile function following non-nerve-sparing radical retropubic prostatectomy: a prospective study. Plast Reconstr Surg 2003;111:1174.
56. Walsh PC. Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy. Urology 2001;57:1020.
57. Moreland RB, Albadawi H, Bratton C, et al. O2-dependent prostanoid synthesis activates functional PGE receptors on corpus cavernosum smooth muscle. Am J Physiol Heart Circ Physiol 2001;281:H552.
58. Montorsi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997;158:1408.
59. Padma-Nathan H, McCullough A, Giuliano F, et al. Nightly post-operative sildenafil dramatically improves the return of spontaneous erections following a bilateral nerve-sparing radical prostatectomy (abstract). J Urol 2003.
60. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004;171:771.
61. Donohue JF, Mullerad M, Paduch DA, Kobylarz K, Li PS, Scardino PT, Mulhall JP. The functional and structural consequences of cavernous nerve injury in the rat model are ameliorated by sildenafil citrate. J Urology 2005.
62. Snyder SH SD, Lai MM, Steiner JP, Hamilton GS, Suzdak PD. Neural actions of immunophilin ligands. Trends Pharmacol Sci 1998;19:21.
63. Burnett AL, Becker RE. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J Urol 2004;171:595.
64. Sezen SF, Blackshaw S, Steiner JP, Burnett AL. FK506 binding protein 12 is expressed in rat penile innervation and upregulated after cavernous nerve injury. Int J Impot Res 2002;14:506.
65. Sezen SF, Hoke A, Burnett AL, Snyder SH. Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat Med 2001;7:1073.
66. Zhang R, Wang Y, Zhang L, Zhang Z, Tsang W, Lu M, Zhang L, Chopp M. Sildenafil induces neurogenesis andpromotes fucntional recovery after stroke in rats. Stroke, 2002;33:2675.
67. Herkommer KNS, Zorn C, Gschwend JE, Volkmer BG. Management of erectile dysfunction after radical prostatectomy. Urologists' assessment vs patient survey responses. Urologe A 2005.
68. Montorsi FMA. Sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2005;2:658.
69. Bennett NE, Donohue J, Parker M, Mulhall JP. Predictors of sildenafil citrate response following radical prostatectomy. J Sex Med Presented at The Annual Meeting of the Sexual Medicine Society of North America, 2005.
70. Raina RL MM, Agarwal A, Sharma R, Goyal KK, Montague DK, et al. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 2003;62:110.
71. Brock G, Nehra A, Lipshultz LI, Karlin GS, Gleave M, Seger M, et al. Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 2003;170:1278.
72. Montorsi F, Nathan HP, McCullough A, Brock GB, Broderick G, Ahuja S, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 2004;172: 1036.
73. Cookson MD, Nadig PW. Long term results with vacuum constriction device. J Urol 1993;149:200.
74. Dutta TC, Eid JF. Vacuum constriction devices for erectile dysfunction: a long-term, prospective study of patients with mild, moderate, and severe dysfunction. Urology 1999;54:891.
75. Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK, et al. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J impot Res 2006;18:77.
76. Raina R, Agarwal A, Allamaneni SS, Lakin MM, Zippe CD. Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy. Urology 2005; 65:360.
77. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. NEJM 1997;336:1.
78. Raina R, Agarwal A, Zippe CD. Management of erectile dysfunction after radical prostatectomy. Urology 2005; 66:923.
79. Mulhall JP, Jahoda AE, Ahmed A, et al. Analysis of the consistency of intraurethral prostaglandin E(1) (MUSE) during at-home use. Urology 2001;58:262.
80. Nehra A, Blute ML, Barrett DM, Moreland RB. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res 2002;14:S38.
81. Dennis RL, McDougal WS. Pharmacological treatment of erectile dysfunction after radical prostatectomy. J Urol 1988;139:775.
82. Briganti A, Salonia A, Zanni G, Fabbri F, Saccá A, Bertini R, et al. Erectile dysfunction and radical prostatectomy: an update. EAU Update Series 2004;2:84.
83. Gontero P, Fontana F, Bagnasacco A, Panella M, Kocjancic E, Pretti G, et al. Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following non-nerve sparing radical prostatectomy? Results from a hemodynamic prospective study. J Urol 2003; 169:2166.
84. Montorsi F, Guazzoni G, Bergamaschi F, Dodesini A, Rigati P, Pizzini G, et al. Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. Urology 1993;42:554.
85. Claro A, de Aboim JE, Maringolo M, Andrade E, Aguiar W, Nogueira M, et al. Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study. Sao Paulo Med 2001; 5:135.
86. Raina R, Lakin MM, Thukral M, Agarwal A, Ausmundson S, Montague DK, et al. Long-term efficacy and compliance of intracorporeal injection for erectile dysfunction following radical prostatectomy. Int J Impot Res 2003;15:318.
87. Mulhall JP, Jahoda AE, Cairney M, Goldstein B, Leitzes R, Woods J, et al. The causes of patient dropout from penile self-injection therapy for impotence. J Urol 1999;162:1291.
88. Minervini A, Ralph DJ, Pryor JP. Outcome of penile prosthesis implantation for treating erectile dysfunction: experience with 504 procedures. BJU Int 2006;97:129.
89. Ramsawh HJ, Morgentaler A, Covino N, Barlow DH, DeWolf WC. Quality of life following simultaneous placement of penile prosthesis with radical prostatectomy. J Urol 2005;174:1395.
90. Akin-Olugbade Y, Ahmed A, Parker M, Guhring P, Mulhall JP. Determinants of patient satisfaction following penile prosthesis surgery. J Sex Med (In Press), 2006.